8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.

Changes in NOTCH1 gene and its regulatory circRNA, hsa_circ_0005986 expression pattern in human gastric adenocarcinoma and human normal fibroblast cell line following the exposure to extremely low frequency magnetic field

Bioeffects Seen

Authors not listed · 2021

Share:

ELF magnetic fields selectively reduced gastric cancer cell survival while protecting normal cells through NOTCH1 gene regulation.

Plain English Summary

Summary written for general audiences

Researchers exposed gastric cancer cells and normal cells to extremely low frequency magnetic fields at different strengths for 18 hours. The magnetic fields decreased cancer cell survival while increasing normal cell survival, and changed the expression of NOTCH1, a gene involved in cancer growth. This suggests ELF magnetic fields might selectively target cancer cells while protecting healthy tissue.

Why This Matters

This study reveals something remarkable: extremely low frequency magnetic fields appear to discriminate between cancer cells and healthy cells at the molecular level. The magnetic fields decreased gastric cancer cell survival by 18 hours of exposure while actually improving normal cell viability. The mechanism appears linked to NOTCH1 gene expression, which was suppressed in cancer cells but enhanced in normal cells. What makes this particularly intriguing is that these are the same frequencies emitted by power lines and many household appliances, typically at much lower intensities. The study used magnetic field strengths of 0.25 to 2 millitesla, which are significantly higher than typical environmental exposures from power lines (usually measured in microtesla). However, certain occupational settings and medical devices can reach these levels. While this research suggests potential therapeutic applications, it also raises questions about how chronic exposure to lower-level ELF fields might affect cellular processes over time. The science demonstrates that magnetic fields can selectively influence gene expression in ways that depend on cell type and field strength.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2021). Changes in NOTCH1 gene and its regulatory circRNA, hsa_circ_0005986 expression pattern in human gastric adenocarcinoma and human normal fibroblast cell line following the exposure to extremely low frequency magnetic field.
Show BibTeX
@article{changes_in_notch1_gene_and_its_regulatory_circrna_hsacirc0005986_expression_pattern_in_human_gastric_adenocarcinoma_and_human_normal_fibroblast_cell_line_following_the_exposure_to_extremely_low_freque_ce4137,
  author = {Unknown},
  title = {Changes in NOTCH1 gene and its regulatory circRNA, hsa_circ_0005986 expression pattern in human gastric adenocarcinoma and human normal fibroblast cell line following the exposure to extremely low frequency magnetic field},
  year = {2021},
  doi = {10.1080/15368378.2021.1891092},
  
}

Quick Questions About This Study

Yes, the study found that magnetic field strengths of 0.25 to 2 millitesla decreased gastric cancer cell survival after 18 hours of exposure, while normal fibroblast cells actually showed improved viability under the same conditions.
NOTCH1 is a gene that regulates cell proliferation and cancer progression. The magnetic field exposure suppressed NOTCH1 expression in cancer cells but increased it in normal cells, suggesting the fields can selectively target harmful versus healthy tissue.
The researchers used magnetic field strengths of 0.25, 0.5, 1, and 2 millitesla. These are much stronger than typical household exposures but similar to levels found near some industrial equipment or medical devices.
Yes, the study found that changes in NOTCH1 gene expression in both cancer and normal cells were dependent on the magnetic field strength, with different millitesla levels producing varying degrees of cellular response.
The researchers suggest this selective effect on cancer versus normal cells through gene expression changes could represent a new approach to cancer treatment, though much more research would be needed for clinical applications.